SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia-Reference-Cited by-同舟云学术

SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia

Published:2020-08 Issue: Volume:306 Page:41-49
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Gallo Antonio,Charriere Sybil,Vimont Alexandre,Chapman M. John,Angoulvant Denis^ORCID,Boccara Franck,Cariou Bertrand^ORCID,Carreau Valérie,Carrié Alain,Bruckert Eric,Béliard Sophie,Angoulvant Denis,Beliard Sophie,Boccara Franck,Bruckert Eric,Cariou Bertrand,Carreau Valérie,Carrie Alain,Charriere Sybil,Cottin Yves,Filippo Mathilde DI.,Dulong Sonia,Durlach Vincent,Farnier Michel,Ferrari Emile,Ferrieres Dorota,Ferrieres Jean,Gallo Antonio,Giral Philippe,Gonbert Sophie,Hankard Regis,Inamo Jocelyn,Kalmykova Olga,Krempf Michel,Moulin Philippe,Paillard François,Peretti Noel,Perrin Agnes,Pierre Rabes Jean,Sultan Ariane,Tounian Patrick,Valero René,Verges Bruno,Yelnik Cecile,Ziegler Olivier

Funder

Agence Nationale de la Recherche

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society;Nordestgaard;Eur. Heart J.,2013

2. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication;Benn;J. Clin. Endocrinol. Metab.,2012

3. Genetic testing for familial hypercholesterolemia among survivors of acute coronary syndrome;Benedek;J. Intern. Med.,2018

4. Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013;Mundal;Eur. J. Prev. Cardiol.,2017

5. The very high cardiovascular risk in heterozygous familial hypercholesterolemia: analysis of 734 French patients;Beliard;J. Clin. Lipidol.,2016

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA);Nutrition, Metabolism and Cardiovascular Diseases;2024-08

2. Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?;Current Opinion in Endocrinology, Diabetes & Obesity;2024-07-05

3. Predictors of cardiovascular risk in familial hypercholesterolemia;Current Opinion in Endocrinology, Diabetes & Obesity;2024-05-08

4. Peripheral artery disease: an underdiagnosed condition in familial hypercholesterolemia? A systematic review;Endocrine;2024-03-08

5. Clinical Impact of Lipoprotein (a) and Cumulative Low-Density Lipoprotein Cholesterol Exposure on Coronary Artery Disease in Patients with Heterozygous Familial Hypercholesterolemia;Journal of Atherosclerosis and Thrombosis;2024